Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01182584
Other study ID # 200811040R
Secondary ID
Status Recruiting
Phase N/A
First received August 12, 2010
Last updated December 21, 2010
Start date December 2009
Est. completion date December 2011

Study information

Verified date December 2010
Source National Taiwan University Hospital
Contact Shyang-Rong Shih, M.D.
Phone 0972653337
Email srshih@ntu.edu.tw
Is FDA regulated No
Health authority Taiwan: Department of Health
Study type Observational

Clinical Trial Summary

Graves' disease is characterized by thyrotoxicosis, goiter, ophthalmopathy and dermopathy. Pathogenesis involves autoimmune process. The investigators think temperatures of the area involved in the inflammation may change. Thus the investigators plan to take temperature pictures of Graves' patients using digital infrared thermal imaging system and observe the change.


Description:

We will recruited patients of Graves' disease from out patient clinics. We will perform thyroid echo and soft tissue echo first. Then we let patients sit before the thermal camera and take thermal images of eyes necks and tibia. After data collection, we analyse the relation between temperature and laboratory data such as thyroid function and autoimmune profiles.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 2011
Est. primary completion date October 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 16 Years to 60 Years
Eligibility Inclusion Criteria:

- Graves' disease patients. Healthy people

Exclusion Criteria:

- Pregnancy. <16 years old or > 60 years old

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Taiwan National Taiwan University Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

See also
  Status Clinical Trial Phase
Completed NCT01950260 - Early Levothyroxine Post Radioactive Iodine Phase 2/Phase 3
Completed NCT01269749 - Radioactive Iodide Therapy for Pediatric Graves' Disease Phase 2
Recruiting NCT06068179 - Graves' Disease Remission Study: MycoMeth Combo Phase 2/Phase 3
Recruiting NCT02114619 - Comparative Study of Different I-131 Doses in Graves' Disease N/A
Completed NCT04383795 - Change of Gut Microbiome in the Treatment of Graves' Disease
Completed NCT02384668 - D-vitamin And Graves' Disease; Morbidity And Relapse Reduction N/A
Completed NCT01885533 - Post-Radioiodine Graves' Management: The PRAGMA-Study N/A
Completed NCT01534169 - Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients Phase 1
Completed NCT00917241 - Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone Phase 4
Completed NCT00004660 - Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy N/A
Completed NCT02205801 - Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy N/A
Recruiting NCT02620085 - Thyroid Disease and Personality Study N/A
Completed NCT00958113 - Autoimmune Thyroid Disease Genetic Study N/A
Completed NCT02727738 - Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole N/A
Completed NCT00697528 - Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy N/A
Completed NCT00150124 - Block-replacement Therapy During Radioiodine Therapy Phase 4
Completed NCT03535090 - Coagulation After Intravenous Methylprednisolone Administration
Not yet recruiting NCT02373995 - Role of the Microbiome in Graves' Orbitopathy Phase 1/Phase 2
Completed NCT00505011 - Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves’ Disease N/A
Completed NCT02107794 - Shared Decision Making in Graves Disease - Graves Disease (GD) Choice N/A